Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases.
To improve the life of the patient, in compliance with ethics and the rules of good biomedical research practice.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.